These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23364535)

  • 1. Significance of divergent expression of prostaglandin EP4 and EP3 receptors in human prostate cancer.
    Huang HF; Shu P; Murphy TF; Aisner S; Fitzhugh VA; Jordan ML
    Mol Cancer Res; 2013 Apr; 11(4):427-39. PubMed ID: 23364535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolocalization of adipocytes and prostaglandin E2 and its four receptor proteins EP1, EP2, EP3, and EP4 in the caprine cervix during spontaneous term labor.
    Gu G; Gao Q; Yuan X; Huang L; Ge L
    Biol Reprod; 2012 May; 86(5):159, 1-10. PubMed ID: 22402965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
    Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
    J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells.
    Kashiwagi E; Shiota M; Yokomizo A; Itsumi M; Inokuchi J; Uchiumi T; Naito S
    Endocr Relat Cancer; 2013 Jun; 20(3):431-41. PubMed ID: 23493387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
    Aso H; Ito S; Mori A; Suganuma N; Morioka M; Takahara N; Kondo M; Hasegawa Y
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):322-9. PubMed ID: 23221043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesis.
    Miyata Y; Ohba K; Matsuo T; Watanabe S; Hayashi T; Sakai H; Kanetake H
    Urology; 2013 Jan; 81(1):136-42. PubMed ID: 23149328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
    Wang X; Klein RD
    Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
    Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal and tissue-specific expression of prostaglandin receptors EP2, EP3, EP4, FP, and cyclooxygenases 1 and 2 in uterus and fetal membranes during bovine pregnancy.
    Arosh JA; Banu SK; Chapdelaine P; Fortier MA
    Endocrinology; 2004 Jan; 145(1):407-17. PubMed ID: 14500566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of PGE2 EP3/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
    Xue R; Jia Z; Kong X; Pi G; Ma S; Yang J
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1656-62. PubMed ID: 24154697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney.
    Morath R; Klein T; Seyberth HW; Nüsing RM
    J Am Soc Nephrol; 1999 Sep; 10(9):1851-60. PubMed ID: 10477136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.
    Cipollone F; Fazia ML; Iezzi A; Cuccurullo C; De Cesare D; Ucchino S; Spigonardo F; Marchetti A; Buttitta F; Paloscia L; Mascellanti M; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1925-31. PubMed ID: 16020747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of prostaglandin E2 receptors (EP2, EP4) in the horse oviduct.
    Ball BA; Scoggin KE; Troedsson MH; Squires EL
    Anim Reprod Sci; 2013 Nov; 142(1-2):35-41. PubMed ID: 24035156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
    J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
    Weems YS; Bridges PJ; Jeoung M; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1.
    Peng Y; Shi J; Du X; Wang L; Klocker H; Mo L; Mo Z; Zhang J
    Int J Biochem Cell Biol; 2013 Mar; 45(3):521-30. PubMed ID: 23246486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.
    Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K
    Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells.
    Ueta M; Matsuoka T; Sotozono C; Kinoshita S
    Cornea; 2012 Nov; 31(11):1294-8. PubMed ID: 22475642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
    Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N
    Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear.
    Hori R; Nakagawa T; Yamamoto N; Hamaguchi K; Ito J
    BMC Neurosci; 2010 Mar; 11():35. PubMed ID: 20219142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.